Ivan T. Hofmann, C.P.A., C.F.F., C.L.P.
`Curriculum Vitae
`
`Professional History
`Gleason IP, a division of Gleason & Associates, P.C. – Vice President and Managing Director
`
`2006 to Present
`
`Ivan Hofmann is a Vice President and Managing Director at Gleason IP. He has years of professional experience
`with a deep specialization in complex intellectual property matters. Mr. Hofmann's IP expertise includes extensive
`litigation support and testifying experience in quantifying financial damages related to patent infringement and
`other intellectual property issues, as well as breach of contract claims, class action law suits and other litigation-
`related matters. His experience includes using statistical, financial, and economic analysis and models related to
`various technical issues. He provides value-added services in all phases of litigation in various capacities, including
`assistance with discovery, depositions, expert opinions, and testimony during trial.
`
`Mr. Hofmann's experience with intellectual property matters includes false advertising cases, theft of trade
`secrets, and trademark infringement matters. He has performed analysis of irreparable harm in preliminary
`injunction hearings and regularly performs analysis of commercial success in connection with secondary
`considerations of nonobviousness. The United States Patent and Trademark Office and the Office of the
`Solicitor has engaged Mr. Hofmann on several projects as an expert in economics regarding intellectual property
`issues involving patents. Mr. Hofmann has experience with intellectual property issues in numerous industries,
`including extensive experience in the pharmaceutical industry.
`
`As a Certified Licensing Professional (CLP), Mr. Hofmann has demonstrated knowledge and experience in
`analyzing license agreements and royalty terms. He assists companies in licensing negotiations with economic
`analysis in licensing agreements. He also has performed royalty audits on behalf of universities and corporations.
`Mr. Hofmann’s extensive knowledge of licensing is useful in his analysis of reasonable royalties in patent
`infringement cases.
`
`Also, Mr. Hofmann has experience in the areas of accounting, auditing, forensic accounting, fraud investigations
`and due diligence work. He has been involved in matters in state and federal courts, as well as domestic and
`international arbitration and other forums for dispute resolution. His experience includes matters with public and
`private companies in a broad range of industries including pharmaceuticals, communications, health care,
`manufacturing, retail, oil and gas, coal, utilities, land development, hospitality, and others.
`
`Deloitte & Touche LLP – Senior Manager
`
`1994 -2006
`
`Mr. Hofmann was a senior manager with the global firm of Deloitte in the Forensic and Dispute Services and
`Assurance and Advisory services departments. He served numerous clients in various industries ranging in size
`from small, privately held companies to large, multi-national Fortune 500 companies.
`
`Education and Certification
`Bachelor of Business Administration, double major in Accounting and Economics, Magna Cum Laude,
` University of Notre Dame, 1994
`Certified Public Accountant, Pennsylvania 1996
`Certified in Financial Forensics, 2008
`Certified Licensing Professional 2010
`
`Professional and Business Affiliations
`American Economic Association, Member
`American Institute of Certified Public Accountants, Member
`Licensing Executives Society, Member
`Pennsylvania Institute of Certified Public Accountants, Member
`Civic Affiliations
`Notre Dame Club of Pittsburgh
`
`Gleason IP, a division of Gleason & Associates, P.C. One Gateway Center, Suite 525 420 Fort Duquesne Boulevard Pittsburgh, PA 15222
`
`Slayback Exhibit 1068, Page 1 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`
`
`
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. v.
`Sandoz Inc., Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.,
`Aurolife Pharma LLC, Sawai Pharmaceutical Co., Ltd., Sawai USA, Inc., Prinston Pharmaceutical
`Inc., Zhejiang Huahai Pharmaceutical Co., Ltd., Huahai US Inc., Solco Healthcare US, LLC,
`Windlas Healthcare, Pvt. Ltd., Windlas Biotech Ltd., Zydus Pharmaceuticals (USA), Inc., Zydus
`Lifesciences Limited, Lupin Ltd., Lupin Pharmaceuticals, Inc. – United States District Court for the
`District of Delaware, 2022 (Deposition)
`
`Royalty Pharma Collection Trust v. Gilead Sciences, Inc. – American Arbitration Association, 2022
`(Deposition)
`
`Trudell Medical International v. D R Burton Healthcare, LLC – United States District Court for the
`Eastern District of North Carolina, Eastern Division, 2022 (Trial)
`
`Novartis Pharmaceuticals Corporation v. HEC Pharm Co. Ltd. and HEC Pharm USA Inc. – United
`States Supreme Court, 2022 (Declaration)
`
`Purdue Pharma L.P., Purdue Pharmaceuticals L.P., and Rhodes Technologies v. Accord Healthcare
`Inc. – United States District Court for the District of Delaware, 2022 (Trial)
`
`Astellas US LLC, Astellas Pharma US, Inc., and Gilead Sciences, Inc. v. Mylan Pharmaceuticals
`Inc. – United States District Court for the Northern District of West Virginia, 2022 (Deposition)
`
`Melinta Therapeutics, LLC, Melinta Subsidiary Corp., and Rempex Pharmaceuticals, Inc. v. Nexus
`Pharmaceuticals, Inc. – United States District Court for the Northern District of Illinois, 2022
`(Declaration)
`
`Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S, v. Zenara Pharma Private Ltd., Biophore
`India Pharmaceuticals Private, Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals
`Company GmbH, Raks Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Aurobindo Pharma Ltd.,
`Aurobindo Pharma USA, Inc., Apotex Inc., Apotex Corp., Apotex Pharmachem Inc., Signa S.A. de
`C.V., Optimus Pharma Pvt. Ltd., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Zydus
`Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited, Sandoz Inc. – United States District Court
`for the District of Delaware, 2022 (Deposition)
`
`Purdue Pharma L.P., Purdue Pharmaceuticals L.P., and Rhodes Technologies v. Accord Healthcare
`Inc. – United States District Court for the District of Delaware, 2022 (Deposition)
`
`Mylan Pharmaceuticals Inc., Celltrion, Inc., and Apotex, Inc. v. Regeneron Pharmaceuticals, Inc. –
`United States Patent Trial and Appeal Board, 2022 (Deposition)
`
`
` 1
`
`
`
`Slayback Exhibit 1068, Page 2 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Bial – Portela & CA S.A., Bial – Holdings, S.A., and Sunovion Pharmaceuticals Inc. v. Alkem
`Laboratories Limited and S&B Pharma, Inc. – United States District Court for the District of
`Delaware, 2022 (Trial)
`
`Alkermes, Inc. and Alkermes Pharma Ireland Limited v. Teva Pharmaceuticals USA, Inc. – United
`States District Court for the District of New Jersey, 2022 (Deposition)
`
`Mylan Pharmaceuticals Inc., Celltrion, Inc., and Apotex, Inc. v. Regeneron Pharmaceuticals, Inc. –
`United States Patent Trial and Appeal Board, 2022 (Declaration)
`
`Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc. – United States District Court for the District
`of New Jersey, 2022 (Trial)
`
`In re Entresto (Sacubitril/Valsartan) Patent Litigation (Novartis Pharmaceuticals Corporation v.
`Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd., Biocon Pharma
`Limited, Biocon Limited, Biocon Pharma, Inc., Crystal Pharmaceutical (Suzhous) Co., Ltd., Laurus
`Labs Limited, Laurus Generics Inc., Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc.,
`Lupin Pharmaceuticals, Inc., Nanjing Noratech Pharmaceutical Co., Limited, Teva Pharmaceuticals
`USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.; Novartis Pharmaceuticals
`Corporation v. Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals Inc., Macleods
`Pharmaceuticals Ltd., Macleods Pharma USA, Inc.; Novartis Pharmaceuticals Corporation v. Dr.
`Reddy’s Laboratories, Inc., Dr. Reddy’s Laboratories, Ltd., Hetero USA Inc., Hetero Labs Limited.,
`Hetero Labs Limited Unit III, MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN
`Life Sciences Private Limited, Novugen Pharma (Malaysia) SDN. BHD., Zydus Pharmaceuticals
`(USA) Inc., Cadila Healthcare Ltd.; and Novartis Pharmaceuticals Corporation v. Mylan
`Pharmaceuticals, Inc. – United States District Court for the District of Delaware, 2022 (Deposition)
`
`Hoffmann-La Roche, Inc., Chugai Pharmaceutical Co. Ltd., and Genentech, Inc. v. Fresenius Kabi
`USA, LLC – United States District Court for the District of Delaware, 2022 (Deposition)
`
`Darren Clevenger and David Bloom on behalf of themselves and all others similarly situated v.
`Welch Foods Inc., A Cooperative, The Promotion in Motion Companies, Inc., a Delaware
`Corporation, and Does 1 through 25, inclusive – United States District Court for the Central District
`of California, 2022 (Declaration)
`
`Gilead Sciences, Inc. v. Apotex, Inc., Lupin Limited, Laurus Labs Limited, Shilpa Medicare
`Limited, Sunshine Lake Pharma Co., Ltd., Natco Pharma Limited, Cipla Limited, Macleods
`Pharmaceuticals Ltd., Hetero USA Inc., Hetero Labs Limited Unit-V, and Hetero Labs Limited –
`United States District Court for the District of Delaware, 2022 (Deposition)
`
`Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc. – United States District Court for the District
`of New Jersey, 2022 (Deposition)
`
`
`2
`
`Slayback Exhibit 1068, Page 3 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`AstraZeneca AB and AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc. and Kindeva
`Drug Delivery, LP – United States District Court for the Northern District of West Virginia, 2022
`(Declaration)
`
`Bial – Portela & CA S.A., Bial – Holding, S.A., and Sunovion Pharmaceuticals Inc. v. Alkem
`Laboratories Limited and S&B Pharma, Inc.; and Bial – Portela & CA S.A., Bial – Holding, S.A.,
`and Sunovion Pharmaceuticals Inc. v. Apotex Inc. and Apotex Corp. – United States District Court
`for the District of Delaware, 2022 (Deposition)
`
`Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc. v. Eugia Pharma Specialities Ltd.,
`Aurobindo Pharma Ltd., and Aurobindo Pharma U.S.A., Inc.; Taiho Pharmaceutical Co., Ltd. and
`Taiho Oncology, Inc. v. Accord Healthcare Inc.; Taiho Pharmaceutical Co., Ltd. and Taiho
`Oncology, Inc. v. Natco Pharma Ltd. and Natco Pharma, Inc.; Taiho Pharmaceutical Co., Ltd. and
`Taiho Oncology, Inc. v. MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc. – United
`States District Court for the District of Delaware, 2022 (Deposition)
`
`Venn Therapeutics v. Corbus Pharmaceuticals Holdings, Inc. – United States District Court for the
`Middle District of Florida, 2022 (Declaration)
`
`Bionpharma Inc. v. CoreRx, Inc. – United States District Court for the Southern District of New
`York, 2021 (Declaration)
`
`Xodus Medical, Inc., Alessio Pigazzi, and Glenn Keilar v. Prime Medical LLC, Symmetry Surgical
`Inc., and G&T Industries, Inc. – United States District Court for the Eastern District of Tennessee,
`2021 (Declaration)
`
`Exela Pharma Sciences, LLC v. Eton Pharmaceuticals, Inc. – United States District Court for the
`District of Delaware, 2021 (Deposition)
`
`Promotion in Motion, Inc. v. Haribo of America, Inc. – United States District Court for the District
`of New Jersey, 2021 (Deposition)
`
`Horizon Medicines LLC and Nuvo Pharmaceuticals (Ireland) Designated Activity Company v. Dr.
`Reddy’s Laboratories, Inc. and Dr. Reddy’s Laboratories Ltd. – United States District Court for the
`District of New Jersey, 2021 (Deposition)
`
`Indivior Inc., Indivior UK Limited, and Aquestive Therapeutics, Inc. v. Dr. Reddy’s Laboratories
`S.A. and Dr. Reddy’s Laboratories, Inc. v. Atlantic Specialty Insurance Company and Berkley
`Insurance Company – United States District Court for the District of New Jersey, 2021 (Deposition)
`
`Xodus Medical, Inc., Alessio Pigazzi, and Glenn Keilar v. Prime Medical LLC, Symmetry Surgical
`Inc., and G&T Industries, Inc. – United States District Court for the Eastern District of Tennessee,
`2021 (Deposition)
`
`3
`
`Slayback Exhibit 1068, Page 4 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Vifor (International) AG and American Regent, Inc. v. Mylan Laboratories Ltd. and Sandoz Inc. –
`United States District Court for the District of New Jersey, 2021 (Trial)
`
`Amgen Inc. v. Sandoz Inc., et al. – United States District Court for the District of New Jersey, 2021
`(Trial)
`
`Vifor (International) AG and American Regent, Inc. v. Mylan Laboratories Ltd. and Sandoz Inc. –
`United States District Court for the District of New Jersey, 2021 (Deposition)
`
`Astellas US LLC, Astellas Pharma US, Inc., and Gilead Sciences, Inc. v. Apotex Inc., et al. – United
`States District Court for the District of Delaware, 2021 (Deposition)
`
`Amgen Inc. v. Amneal Pharmaceuticals LLC, et al. and Slate Run Pharmaceuticals, LLC v. Amgen
`Inc. – United States District Court for the District of Delaware, 2021 (Hearing)
`
`Amgen Inc. v. Sandoz Inc., et al. – United States District Court for the District of New Jersey, 2021
`(Deposition)
`
`Amgen Inc. v. Amneal Pharmaceuticals LLC, et al. and Slate Run Pharmaceuticals, LLC v. Amgen
`Inc. – United States District Court for the District of Delaware, 2021 (Deposition)
`
`Martin R. Prince, M.D., Ph.D. v. General Electric Company – JAMS Arbitration, 2021 (Hearing)
`
`Allergan Sales, LLC and Allergan, Inc. v. Sandoz, Inc. and Alcon Laboratories, Inc. – United States
`District Court for the District of New Jersey, 2021 (Deposition)
`
`Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC – United States District Court for
`the District of Delaware, 2021 (Trial)
`
`Martin R. Prince, M.D., Ph.D. v. General Electric Company – JAMS Arbitration, 2021 (Deposition)
`
`Genzyme Corp. and The Regents of the University of Michigan v. Apotex Inc. and Apotex Corp., et
`al. – United States District Court for the District of Delaware, 2020 (Deposition)
`
`Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC – United States District Court for
`the District of Delaware, 2020 (Deposition)
`
`Philips North America LLC, Philips Medical Systems Nederland B.V., Philips India Ltd., Philips
`Medical Systems (Cleveland), Inc., Philips Medical System Technologies Ltd., and Koninklijke
`Philips N.V. v. 626 Holdings, Inc. and Alexander Kalish – United States District Court for the
`District of Florida, 2020 (Deposition)
`
`
`4
`
`Slayback Exhibit 1068, Page 5 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV v. Teva Pharmaceuticals USA, Inc. –
`United States District Court for the District of New Jersey, 2020 (Trial)
`
`Cytonome/ST, LLC v. NanoCellect Biomedical, Inc. – United States District Court for the District of
`Delaware, 2020 (Deposition)
`
`UCB, Inc., UCB Pharma GmbH, and LTS Lohmann Therapie-Systeme AG v. Actavis Laboratories
`UT, Inc. – United States District Court for the District of Delaware, 2020 (Trial)
`
`H. Lundbeck A/S, Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals U.S.A., Inc.,
`Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc. v. Apotex
`Inc., et al. – United States District Court for the District of Delaware, 2020 (Deposition)
`
`AstraZeneca AB and AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc. and 3M
`Company – United States District Court for the Northern District of West Virginia, 2020
`(Deposition)
`
`Pharmacyclics LLC and Janssen Biotech, Inc. v. Fresenius Kabi USA, LLC, et al. – United States
`District Court for the District of Delaware, 2020 (Deposition)
`
`UCB, Inc., UCB Pharma GmbH, and LTS Lohmann Therapie-Systeme AG v. Actavis Laboratories
`UT, Inc. – United States District Court for the District of Delaware, 2020 (Deposition)
`
`Actelion Pharmaceuticals Ltd. v. Zydus Pharmaceuticals (USA) Inc., et al. – United States District
`Court for the District of New Jersey, 2020 (Deposition)
`
`Club Champion LLC v. True Spec Golf LLC – United States Patent Trial and Appeal Board, 2020
`(Declaration, Deposition)
`
`Amgen Inc. v. Alexion Pharmaceuticals, Inc. – United States Patent Trial and Appeal Board, 2020
`(Declarations, Deposition)
`
`Pfizer Inc., PF Prism C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, and PF
`Prism IMB B.V. v. Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. – United States
`District Court for the District of Delaware, 2020 (Deposition)
`
`Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited v. Hikma Pharmaceuticals USA
`Inc., Hikma Pharmaceuticals International Limited, Dr. Reddy’s Laboratories, Inc., and Dr. Reddy’s
`Laboratories, Ltd. – United States District Court for the District of Nevada, 2020 (Trial)
`
`Autoliv ASP, Inc. v. Hyundai Mobis Co. Ltd. and Mobis Alabama L.L.C. – United States District
`Court for the Middle District of Alabama, 2019 (Deposition)
`
`
`5
`
`Slayback Exhibit 1068, Page 6 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Biogen International GmbH and Biogen MA Inc. v. Sandoz Inc., Prinston Pharmaceutical Inc., MSN
`Laboratories Private Limited and MSN Pharmaceuticals Inc., Zydus Pharmaceuticals (USA) Inc.,
`Hetero USA Inc., Hetero Labs Limited Unit-III, and Hetero Labs Limited, and Shilpa Medicare
`Limited – United States District Court for the District of Delaware, 2019 (Trial)
`
`Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV v. Teva Pharmaceuticals USA, Inc. –
`United States District Court for the District of New Jersey, 2019 (Deposition)
`
`Adapt Pharma Operations Limited, Adapt Pharma Inc., Adapt Pharma Limited, and Opiant
`Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. –
`United States District Court for the District of New Jersey, 2019 (Trial)
`
`Biogen International GmbH and Biogen MA Inc. v. Sandoz Inc., Prinston Pharmaceutical Inc., MSN
`Laboratories Private Limited and MSN Pharmaceuticals Inc., Zydus Pharmaceuticals (USA) Inc.,
`Sawai USA, Inc. and Sawai Pharmaceutical Co., Ltd., Aurobindo Pharma U.S.A., Inc. and
`Aurobindo Pharma USA LLC, Hetero USA Inc., Hetero Labs Limited Unit-III, and Hetero Labs
`Limited, and Shilpa Medicare Limited – United States District Court for the District of Delaware,
`2019 (Deposition)
`
`Biogen International GmbH and Biogen MA Inc. v. Mylan Pharmaceuticals, Inc. – United States
`District Court for the District of West Virginia, 2019 (Deposition)
`
`Adapt Pharma Operations Limited, Adapt Pharma Inc., Adapt Pharma Limited, and Opiant
`Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. –
`United States District Court for the District of New Jersey, 2019 (Deposition)
`
`Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited v. Hikma Pharmaceuticals USA
`Inc., Hikma Pharmaceuticals International Limited, Dr. Reddy’s Laboratories, Inc., and Dr. Reddy’s
`Laboratories, Ltd. – United States District Court for the District of Nevada, 2019 (Deposition)
`
`Galderma Laboratories, L.P. Galderma, S.A., and Nestlé Skin Health S.A. v. Teva Pharmaceuticals
`USA, Inc. – United States District Court for the District of Delaware, 2019 (Trial)
`
`Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. v.
`Actavis Elizabeth LLC, Actavis LLC, and Actavis Inc., et al. – United States District Court for the
`District of Delaware, 2019 (Deposition)
`
`Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc., et al. – United States District Court
`for the District of Delaware, 2019 (Declaration, Deposition)
`
`True Spec Golf LLC and Club-Conex LLC v. Club Champion LLC – United States District Court
`for the Southern District of New York, 2019 (Declaration, Deposition)
`
`
`6
`
`Slayback Exhibit 1068, Page 7 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Galderma Laboratories, L.P. Galderma, S.A., and Nestlé Skin Health S.A. v. Teva Pharmaceuticals
`USA, Inc. – United States District Court for the District of Delaware, 2019 (Deposition)
`
`Astellas Pharma Inc., Astellas US LLC, Astellas Pharma US, Inc., Medivation LLC., Medivation
`Prostate Therapeutics LLC, and The Regents of The University of California v. Zydus
`Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. – United States District Court for the
`District of Delaware, 2019 (Deposition)
`
`Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals,
`Inc., and Wyeth LLC v. Actavis Laboratories FL, Inc. – United States District Court for the District
`of New Jersey, 2019 (Deposition)
`
`Figuli Venture Holdings LLC and David J. Figuli v. Arist Education System LLC and Bertelsmann,
`Inc. – JAMS Arbitration, 2019 (Hearing)
`
`Galderma Laboratories, L.P., Nestlé Skin Health S.A., and TCD Royalty Sub LLC v. Sun
`Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. – United States District
`Court for the District of Delaware, 2018 (Trial)
`
`Indivior Inc., Indivior UK Limited, and Aquestive Therapeutics, Inc. v. Dr. Reddy’s Laboratories
`S.A. and Dr. Reddy’s Laboratories, Inc. – United States District Court for the District of New Jersey,
`2018 (Declaration)
`
`BTG International Limited, Janssen Biotech, Inc., Janssen Oncology, Inc., Janssen Research &
`Development, LLC v. Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC,
`Dr. Reddy’s Laboratories, Inc., Dr. Reddy’s Laboratories, Ltd., Mylan Pharmaceuticals Inc., Mylan,
`Inc., Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corp., Hikma Pharmaceuticals,
`LLC, Wockhardt Bio AG, Wockhardt USA LLC, Wockhardt Ltd. and Amerigen Pharmaceuticals,
`Inc, Amerigen Pharmaceuticals Ltd. – United States Court of Appeal for the Federal Circuit, 2018
`(Declaration)
`
`Galderma Laboratories, L.P., Nestlé Skin Health S.A., and TCD Royalty Sub LLC v. Sun
`Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. – United States District
`Court for the District of Delaware, 2018 (Deposition)
`
`Morphosys AG v. Janssen Biotech, Inc., Genmab US, Inc. and Genmab A/S – United States District
`Court for the District of Delaware, 2018 (Deposition)
`
`Genentech, Inc., Biogen, Inc. Hoffmann-La Roche, Inc. and City of Hope v. Celltrion, Inc., Celltrion
`Healthcare, Co., Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals International
`GmbH – United States District Court for the District of New Jersey, 2018 (Declaration, Deposition)
`
`
`7
`
`Slayback Exhibit 1068, Page 8 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`Alcon Research Ltd. v. Watson Laboratories, Inc. – United States District Court for the District of
`Delaware, 2018 (Deposition)
`
`BTG International Limited, Janssen Biotech, Inc., Janssen Oncology, Inc., Janssen Research &
`Development, LLC v. Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC,
`Apotex Corp., Apotex Inc., Citron Pharma LLC, Dr. Reddy’s Laboratories, Inc., Dr. Reddy’s
`Laboratories, Ltd., Mylan Pharmaceuticals Inc., Mylan, Inc., Par Pharmaceutical, Inc., Par
`Pharmaceutical Companies, Inc., Sun Pharmaceuticals Industries, Ltd., Sun Pharmaceuticals
`Industries, Inc., Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corp., Hikma
`Pharmaceuticals, LLC, Wockhardt Bio AG, Wockhardt USA LLC, and Wockhardt Ltd. – United
`States District Court for the District of New Jersey, 2018 (Trial)
`
`Indivior Inc., Indivior UK Limited, and Aquestive Therapeutics, Inc. v. Dr. Reddy’s Laboratories
`S.A. and Dr. Reddy’s Laboratories, Inc. – United States District Court for the District of New Jersey,
`2018 (Declaration)
`
`Hospira, Inc. v. Fresenius Kabi USA, LLC – United States District Court for the Northern District of
`Illinois, Eastern Division, 2018 (Deposition)
`
`Ameranth, Inc. v. Pizza Hut, Inc., Pizza Hut of America, Inc. and QuikOrder, Inc. – United States
`District Court for the District of Southern California, 2018 (Deposition)
`
`ApoPharma Inc., ApoPharma USA, Inc., and Apotex Technologies Inc. v. Taro Pharmaceutical
`Industries Ltd. and Taro Pharmaceuticals, U.S.A., Inc. – United States District Court for the Eastern
`District of Texas, 2018 (Deposition)
`
`Purdue Pharma L.P., Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. and Grünenthal
`GmbH v. Alvogen Pine Brook LLC – United States District Court for the District of Delaware, 2018
`(Deposition)
`
`Bayer Intellectual Property GmbH, Bayer Pharma AG, and Janssen Pharmaceuticals, Inc. v.
`Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Breckenridge Pharmaceutical, Inc.,
`Invagen Pharmaceuticals, Inc., Micro Labs Ltd., Micro Labs USA Inc., Mylan Pharmaceuticals, Inc.,
`Prinston Pharmaceutical Inc., Sigmapharm Laboratories, LLC, Torrent Pharmaceuticals, Limited and
`Torrent Pharma Inc. – United States District Court for the District of Delaware, 2018 (Trial)
`
`Alnylam Pharmaceuticals, Inc. v. Dicerna Pharmaceuticals, Inc. – Superior Court Department,
`Commonwealth of Massachusetts, 2018 (Deposition)
`
`Shire Orphan Therapies LLC and Sanofi-Aventis Deutschland GmbH v. Fresenius Kabi USA, LLC
`– United States District Court for the District of Delaware, 2018 (Trial)
`
`
`
`8
`
`Slayback Exhibit 1068, Page 9 of 9
`Slayback v. Eye Therapies - IPR2022-00142
`
`